Nicholls NEJM 2025
2023 IGNYTE Award Nominee for Best in Center Grade Ruby Finley vs
Found Health's website references clinical trial data showing that in a 68-week trial studying Wegovy (semaglutide 2.4 mg), the average weight loss was approximately 15% when paired with diet and exercise changes
5,6 In addition, receptor activator of nuclear factor kappa beta ligand (RANKL), that plays a crucial role in osteoclast activity and bone resorption, 21 also directly influences pancreatic beta-cell function and overall metabolism, with its activity being compromised in obesity and T2D
Comparing Semaglutide to Other GLP-1 Options Semaglutide and tirzepatide both lower hunger and improve metabolic control, but tirzepatide targets two receptors instead of one, sometimes producing faster results in clinical comparisons
(2) lower glucocorticoid receptor mRNA expression in the CA1 hippocampal region, but not in the dentate gyrus or the PVN